These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7647019)

  • 1. Development of resistance to activated protein C during pregnancy.
    Cumming AM; Tait RC; Fildes S; Yoong A; Keeney S; Hay CR
    Br J Haematol; 1995 Jul; 90(3):725-7. PubMed ID: 7647019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of resistance to activated protein C in the course of pregnancy and prevalence of factor V mutation.
    Mimuro S; Lahoud R; Beutler L; Trudinger B
    Aust N Z J Obstet Gynaecol; 1998 May; 38(2):200-4. PubMed ID: 9653861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemostatic changes and acquired activated protein C resistance in normal pregnancy.
    Mahieu B; Jacobs N; Mahieu S; Naelaerts K; Vertessen F; Weyler J; Jacquemyn Y; Van der Planken M
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):685-8. PubMed ID: 17890957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V; Leone G
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to activated protein C in unselected patients with arterial and venous thrombosis.
    Faioni EM; Razzari C; Martinelli I; Panzeri D; Franchi F; Mannucci PM
    Am J Hematol; 1997 Jun; 55(2):59-64. PubMed ID: 9208999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism.
    Bergrem A; Dahm AE; Jacobsen AF; Mowinckel MC; Sandvik L; Sandset PM
    Br J Haematol; 2011 Jul; 154(2):241-7. PubMed ID: 21564075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.
    Dahlbäck B; Zöller B; Hillarp A
    Haemostasis; 1996 Oct; 26 Suppl 4():301-14. PubMed ID: 8979136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Search for mutations in the genes for coagulation factors V and VIII with a possible predisposition to activated protein C resistance.
    Bokarewa MI; Falk G; Bremme K; Blombäck M; Wiman B
    Eur J Clin Invest; 1997 Apr; 27(4):340-5. PubMed ID: 9134384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced anticoagulant response to activated protein C in patients with IDDM.
    Krugluger W; Kopp HP; Schernthaner G; Hopmeier P
    Diabetes; 1995 Sep; 44(9):1033-7. PubMed ID: 7657025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of smoking as a risk factor for activated protein C resistance during pregnancy.
    Kafkas S; Kalkan U; Bolaman Z; Sanci M; Yüksel H; Odabaşi AR
    Gynecol Obstet Invest; 2007; 64(2):89-94. PubMed ID: 17314487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated-protein-C resistance in cancer patients.
    Green D; Maliekel K; Sushko E; Akhtar R; Soff GA
    Haemostasis; 1997; 27(3):112-8. PubMed ID: 9306127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis.
    Dahlbäck B
    Rev Invest Clin; 1997 May; 49 Suppl 1():3-5. PubMed ID: 9291738
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
    Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
    J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated protein C sensitivity ratio in pregnant women at delivery.
    Mathonnet F; de Mazancourt P; Bastenaire B; Morot M; Benattar N; Beufé S; Borg JY; Giudicelli Y
    Br J Haematol; 1996 Jan; 92(1):244-6. PubMed ID: 8562404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procoagulant and anticoagulant properties of coagulation factor V: factor V Leiden (APC resistance) causes hypercoagulability by dual mechanisms.
    Dahlbäck B
    J Lab Clin Med; 1999 May; 133(5):415-22. PubMed ID: 10235124
    [No Abstract]   [Full Text] [Related]  

  • 19. Variability of the response to activated protein C during normal pregnancy.
    Bokarewa MI; Wramsby M; Bremme K; Blombäck M
    Blood Coagul Fibrinolysis; 1997 Jun; 8(4):239-44. PubMed ID: 9199821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of three reactants for the detection of activated protein C resistance due to mutation of factor V Leiden during pregnancy].
    Magdelaine A; Soubrier F; Berkane N; Uzan S; Verdy E
    Ann Biol Clin (Paris); 1998; 56(4):445-50. PubMed ID: 9754280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.